Evidence map›Paper›PMID 37987972›Full record

ArticleJournal of applied genetics2024

lncRNA MIAT promotes luminal B breast cancer cell proliferation, migration, and invasion in vitro.

Jintao Mi, Hongsheng Zhang, Xuemei Jiang, Ying Yi, Weiwei Cao, Chunjiao Song, Chengliang Yuan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of applied genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jintao MiMolecular Immunology, College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China.
Hongsheng ZhangMolecular Immunology, College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China.
Xuemei JiangDepartment of Breast Surgery, People's Hospital of Deyang City, Deyang, 618000, Sichuan, China.
Ying YiDepartment of Breast Surgery, People's Hospital of Deyang City, Deyang, 618000, Sichuan, China.
Weiwei CaoDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, 618000, Sichuan, China.
Chunjiao SongDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, 618000, Sichuan, China.
Chengliang YuanDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, 618000, Sichuan, China. Daghdibi@gmail.com.
Deyang Stomatological Hospital · CNChengdu University of Traditional Chinese Medicine · CN

Funding

Xinglin Scholars YYZX2021018
6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) play a role in the emergence and progression of several human tumors, including luminal B breast cancer (BC). The biological functions and potential mechanisms of lncRNA myocardial infarction-associated transcripts (MIAT) in luminal B BC, on the contrary, are unknown. In this work, we used UALCAN database analysis to find high expression of lncRNA MIAT in luminal BC tissues and also confirmed high levels of lncRNA MIAT expression in luminal B BC tissues and cells. In vitro knockdown of MIAT inhibited the proliferation, migration, and invasion of BT474 cells. In addition, we found that miR-150-5p levels were significantly reduced in luminal B BC specimens and cells, and miR-150-5p levels were significantly increased when MIAT was knocked down. And TIMER database analysis showed that MIAT was positively associated with PDL1. Through bioinformatic tools and in vitro experiments, lncRNA MIAT could function as a competitive endogenous RNA (CeRNA) to further regulate programmed cell death ligand 1 (PDL1) expression by directly sponging miR-150-5p. In conclusion, our data suggest that MIAT, an oncogene, may sponge miR-150-5p to regulate PDL1 expression and affect proliferation, migration, and invasion in luminal B BC in vitro.

Indexed as

Breast NeoplasmsMicroRNAsRNA, Long NoncodingCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMicroRNAsRNA, Long NoncodinglncRNA MIATLuminal B breast cancermiR-150-5pPDL1

Identifiers

PMID37987972
OpenAlexW4388861639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.